Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This medical study is an assessment of clinical response in women with Posttraumatic Stress
Disorder (PTSD) due to domestic violence or rape trauma when treated with risperidone.
Response to risperidone or placebo (inactive drug) is measured by Clinician Administered PTSD
Scale (CAPS) and Treatment Outcomes PTSD Scale (TOP-8). Second, the effect of risperidone on
depressive and anxiety symptoms will be assessed using the Hamilton Rating Scale for Anxiety,
Hamilton Rating Scale for Depression and the Clinical Global Impression.